PHENELZINE - ACETYLATOR STATUS AND CLINICAL-RESPONSE

被引：7

作者：

SANDERS, GL

RAWLINS, MD

机构：

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1979年 / 7卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1979.tb00985.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：451 / 452

页数：2

共 17 条

[1] URINARY-EXCRETION OF PHENELZINE [J].

CADDY, B ;

STEAD, AH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 6 (02) :185-188

[2]

CARR A, 1974, LANCET, V2, P412

[3]

DAVIDSON J, 1978, AM J PSYCHIAT, V135, P467

[4]

DAVIDSON J, 1978, AM J PSYCHIAT, V135, P470

[5]

DEVADATTA S, 1960, Bull World Health Organ, V23, P587

[6]

EVANS DAP, 1965, CLIN PHARMACOL THER, V6, P430

[7] GENETIC CONTROL OF ISONIAZID METABOLISM IN MAN [J].

EVANS, DAP ;

MANLEY, KA ;

MCKUSICK, VA .

BRITISH MEDICAL JOURNAL, 1960, 2 (AUG13) :485-491

[8] RELATIONSHIP BETWEEN ACETYLATOR STATUS AND INHIBITION OF MONOAMINE-OXIDASE, EXCRETION OF FREE DRUG AND ANTIDEPRESSANT RESPONSE IN DEPRESSED-PATIENTS ON PHENELZINE [J].

JOHNSTONE, EC .

PSYCHOPHARMACOLOGIA, 1976, 46 (03) :289-294

[9]

JOHNSTONE EC, 1973, LANCET, V1, P567

[10] DISEASE AND ACETYLATION POLYMORPHISM [J].

LUNDE, PKM ;

FRISLID, K ;

HANSTEEN, V .

CLINICAL PHARMACOKINETICS, 1977, 2 (03) :182-197

← 1 2 →